These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24481662)

  • 1. EMMPRIN co-expressed with matrix metalloproteinases predicts poor prognosis in patients with osteosarcoma.
    Futamura N; Nishida Y; Urakawa H; Kozawa E; Ikuta K; Hamada S; Ishiguro N
    Tumour Biol; 2014 Jun; 35(6):5159-65. PubMed ID: 24481662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of membrane-type matrix metalloproteinase-1 is correlated with poor prognosis in patients with osteosarcoma.
    Uchibori M; Nishida Y; Nagasaka T; Yamada Y; Nakanishi K; Ishiguro N
    Int J Oncol; 2006 Jan; 28(1):33-42. PubMed ID: 16327977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EMMPRIN expression is associated with metastatic progression in osteosarcoma.
    Kim HS; Kim HJ; Lee MR; Han I
    BMC Cancer; 2021 Sep; 21(1):1059. PubMed ID: 34565336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gelatinase A, membrane type 1 matrix metalloproteinase, and extracellular matrix metalloproteinase inducer mRNA expression: correlation with invasive growth of breast cancer.
    Dalberg K; Eriksson E; Enberg U; Kjellman M; Bäckdahl M
    World J Surg; 2000 Mar; 24(3):334-40. PubMed ID: 10658069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADAM17 is associated with EMMPRIN and predicts poor prognosis in patients with uterine cervical carcinoma.
    Xu Q; Ying M; Chen G; Lin A; Xie Y; Ohara N; Zhou D
    Tumour Biol; 2014 Aug; 35(8):7575-86. PubMed ID: 24793016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcifying Cystic Odontogenic Tumour: immunohistochemical expression of matrix metalloproteinases, their inhibitors (TIMPs and RECK) and inducer (EMMPRIN).
    Prosdócimi FC; Rodini CO; Sogayar MC; Sousa SC; Xavier FC; Paiva KB
    J Oral Pathol Med; 2014 Aug; 43(7):545-53. PubMed ID: 24484176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of matrix metalloproteinase 2 and extracellular matrix metalloproteinase inducer are unfavorable postoperative prognostic factors in intrahepatic cholangiocarcinoma.
    Zhang C; Tu Z; Du S; Wang Y; Wang Q
    Pathol Oncol Res; 2010 Mar; 16(1):47-53. PubMed ID: 19629755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular localization of EMMPRIN predicts prognosis of patients with operable lung adenocarcinoma independent from MMP-2 and MMP-9.
    Sienel W; Polzer B; Elshawi K; Lindner M; Morresi-Hauf A; Vay C; Eder F; Passlick B; Klein CA
    Mod Pathol; 2008 Sep; 21(9):1130-8. PubMed ID: 18567995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of extracellular matrix metalloproteinase inducer glycosylation in regulating matrix metalloproteinases in periodontitis.
    Zhang Z; Yang X; Zhang H; Liu X; Pan S; Li C
    J Periodontal Res; 2018 Jun; 53(3):391-402. PubMed ID: 29315565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of EMMPRIN and MMP-2 in the prognosis of primary cutaneous malignant melanoma.
    Chen T; Zhu J
    Med Oncol; 2010 Dec; 27(4):1185-91. PubMed ID: 19921476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emmprin, a cell surface inducer of matrix metalloproteinases (MMPs), is expressed in T-cell lymphomas.
    Nabeshima K; Suzumiya J; Nagano M; Ohshima K; Toole BP; Tamura K; Iwasaki H; Kikuchi M
    J Pathol; 2004 Mar; 202(3):341-51. PubMed ID: 14991900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VEGF and EMMPRIN expression correlates with survival of patients with osteosarcoma.
    Zhou Q; Zhu Y; Deng Z; Long H; Zhang S; Chen X
    Surg Oncol; 2011 Mar; 20(1):13-9. PubMed ID: 19836228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical implications and prognostic value of EMMPRIN/CD147 and MMP2 expression in pediatric gliomas.
    Gu J; Zhang C; Chen R; Pan J; Wang Y; Ming M; Gui W; Wang D
    Eur J Pediatr; 2009 Jun; 168(6):705-10. PubMed ID: 18795327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated expression of extracellular matrix metalloproteinase inducer (CD147) and membrane-type matrix metalloproteinases in venous leg ulcers.
    Norgauer J; Hildenbrand T; Idzko M; Panther E; Bandemir E; Hartmann M; Vanscheidt W; Herouy Y
    Br J Dermatol; 2002 Dec; 147(6):1180-6. PubMed ID: 12452868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membrane type 1 matrix metalloproteinase (MT1-MMP/MMP-14) cleaves and releases a 22-kDa extracellular matrix metalloproteinase inducer (EMMPRIN) fragment from tumor cells.
    Egawa N; Koshikawa N; Tomari T; Nabeshima K; Isobe T; Seiki M
    J Biol Chem; 2006 Dec; 281(49):37576-85. PubMed ID: 17050542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular matrix metalloproteinase inducer is a negative prognostic factor of pediatric medulloblastoma.
    Chu T; Chen X; Yu J; Xiao J; Fu Z
    Pathol Oncol Res; 2011 Sep; 17(3):705-11. PubMed ID: 21448785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of extracellular matrix metalloproteinase inducer (EMMPRIN) and its related extracellular matrix degrading enzymes in the endometrium during estrous cycle and early gestation in cattle.
    Mishra B; Kizaki K; Koshi K; Ushizawa K; Takahashi T; Hosoe M; Sato T; Ito A; Hashizume K
    Reprod Biol Endocrinol; 2010 Jun; 8():60. PubMed ID: 20540754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of extracellular matrix metalloproteinase inducer and matrix metalloproteinase 2 in epithelial ovarian cancer.
    Sillanpää S; Anttila M; Suhonen K; Hämäläinen K; Turpeenniemi-Hujanen T; Puistola U; Tammi M; Sironen R; Saarikoski S; Kosma VM
    Tumour Biol; 2007; 28(5):280-9. PubMed ID: 17962725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between the Wnt/β-catenin signaling pathway and the EMMPRIN/MMP-2, 9 route in periodontitis.
    Liu X; Zhang Z; Pan S; Shang S; Li C
    J Periodontal Res; 2018 Oct; 53(5):842-852. PubMed ID: 29900539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and clinical significance of extracellular matrix metalloproteinase inducer, EMMPRIN/CD147, in human osteosarcoma.
    Lu Q; Lv G; Kim A; Ha JM; Kim S
    Oncol Lett; 2013 Jan; 5(1):201-207. PubMed ID: 23255920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.